Botanical species · safety record

Ligustrum vulgare

The EFSA Compendium of Botanicals holds 1 constituent measurement and 1 adverse-effect record for Ligustrum vulgare. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ligustrum vulgare L.

1Constituent measurements

1Safety records

2Cited sources

6Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 6 licensed products naming Ligustrum vulgare as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Jeunes pousses
Young shoots

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Pyridine alkaloids	Fruit unspecified	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Fruit peel	—	Human (as organism)	Case report	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Czerwinska, Monika E., Ziarek, Marlena., Bazylko, Agnieszka., Osinska, Ewa., Kiss, Anna K. Quantitative Determination of Secoiridoids and Phenylpropanoids in Different Extracts of Ligustrum Vulgare L. Leaves by a Validated HPTLC-Photodensitometry Method . Phytochemical analysis, 2015, vol. 26, no. 4, p. 253-260. DOI
WILLEMS, M. A GLUCOSIDIC ALKALOID ARTIFACT, ORIGINATED FROM SECOIRIDOID GLUCOSIDES FROM FRUITS OF LIGUSTRUM-VULGARE L . Archiv der pharmazie, 1988, vol. 321, no. 6, p. 357-358. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature